This particular effect might suggest a distinctive therapy effect depending on the injury condition, along with the general content of the cytoprotection concept (i.e., maintained cell integrity against different noxious agents injurious effects) (reviewed elsewhere, see [1,3,4,5,6,8,9,32,33,34,92])
And even after people enroll, Milne wrote in an email to Undark, the substances short half-life would make it difficult for the researchers to ensure that participants are sticking with the trial protocol and not supplementing with gray market BPC-157
Always use different injection sites for each compound
It's a simple, foundational step that protects your investment, your time, and the validity of your hard-earned data